Sorrento Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Sorrento Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2023.
  • Sorrento Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2023 was 551M shares, a 26.3% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 551M +115M +26.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 551M +176M +46.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 523M +208M +66.2% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 468M +165M +54.3% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 436M +138M +46.5% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 375M +89.5M +31.3% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 315M +39.3M +14.3% Dec 31, 2021 10-K 2023-03-16
Q3 2021 303M +41.7M +15.9% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 298M +66.1M +28.5% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 286M +81.1M +39.6% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 275M +107M +64.1% Dec 31, 2020 10-K 2022-03-11
Q3 2020 262M +131M +99.8% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 232M +109M +89% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 205M +82.3M +67.2% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 168M +45.5M +37.2% Dec 31, 2019 10-K 2021-02-19
Q3 2019 131M +12.1M +10.2% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 123M +6.4M +5.51% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 122M +31.3M +34.4% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 122M +39.4M +47.5% Dec 31, 2018 10-K 2020-03-03
Q3 2018 119M +40.3M +51.4% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 116M +39.7M +51.9% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 91M +40.1M +78.9% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 82.9M +32M +62.9% Dec 31, 2017 8-K 2019-06-17
Q3 2017 78.5M +20.9M +36.4% Sep 30, 2017 10-Q/A 2018-02-27
Q2 2017 76.5M +11.1M +16.9% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 50.9M +12.5M +32.6% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 50.9M +13.1M +34.7% Dec 31, 2016 10-K 2018-03-16
Q3 2016 57.6M +19.8M +52.5% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 65.4M +29.1M +79.8% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 38.4M +2.12M +5.86% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 37.8M +1.59M +4.39% Dec 31, 2015 10-K/A 2017-03-27
Q3 2015 37.8M +9.23M +32.4% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 36.4M +7.86M +27.5% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 36.3M +13.2M +57.3% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 36.2M 0 0% Dec 31, 2014 10-K 2016-03-15
Q3 2014 28.5M +12.1M +73.1% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 28.5M +15.1M +112% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 23.1M -313M -93.1% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 36.2M +24.2M +201% Dec 31, 2013 10-K 2015-03-16
Q3 2013 16.5M -283M -94.5% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 13.4M -286M -95.5% Jun 30, 2013 10-Q 2013-08-13
Q1 2013 336M +73.7M +28.1% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 12M -250M -95.4% Dec 31, 2012 10-K 2014-04-01
Q3 2012 300M +50.1M +20% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 300M +50.1M +20% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 262M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 262M +11.5M +4.6% Dec 31, 2011 10-K/A 2013-03-27
Q3 2011 250M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 250M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 251M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.